| Filed On | Filing |
|---|---|
| 17 Jun 2025 |
8-K/A: Submission of Matters to a Vote of Security Holders
At the 2025 Annual Meeting, consistent with the recommendation of the board of directors of the Company (the “Board”), the Company’s stockholders approved, on a non-binding advisory basis, to hold future stockholder advisory votes on the... |
| 07 Aug 2019 |
8-K/A: Results of Operations and Financial Condition
No FT500 DLTs Reported at Second Cell Dose Level in Monotherapy Arm or at First Cell Dose Level in Checkpoint Inhibitor Combination Arm in Solid Tumor Study |
Loading...